Global Intravenous Filter Market Size, Share & Trends Analysis 2024-2030 MedCore

In 2023, the worldwide intravenous filter market exhibited a total worth of $159.3 million, marking a 5.0% upturn from the $151.7 million recorded in 2022. Projections for the upcoming period indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 4.2%, ultimately reaching $212.7 million. Presently, the global intravenous filter market is under the dominance of Pall Corporation, GVS, and ITW Filtertek.

Our comprehensive medical market research encompassed an extensive analysis of more than 10 intravenous filter companies across seven continents. Employing a rigorous methodology, we delved into market sizes, unit sales, company market shares, and generated precise forecasts.

DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Value & Growth Trends
• Forecasts Until 2030, and Historical Data to 2020
• Market Drivers & Limiters for Each Segment
• Competitive Analysis with Market Shares for Each Segment
• Recent Mergers & Acquisitions

COVID-19 Impact

• Disease Overviews and Demographic Information
• Company Profiles, Product Portfolios and SWOT for Top Competitors

GLOBAL INTRAVENOUS FILTER MARKET INSIGHTS

The healthcare industry is increasingly acknowledging the paramount significance of patient safety throughout intravenous (IV) therapy. Globally, regulatory authorities and healthcare institutions are placing growing emphasis on maintaining the highest standards of patient care. To meet these stringent standards, healthcare providers are required to adhere to guidelines and regulations established by renowned organizations such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These regulatory bodies play a pivotal role in driving the widespread adoption of IV filters as an essential component of standard healthcare protocols. By steadfastly adhering to these guidelines, healthcare providers can confidently ensure the well-being of their patients and uphold the highest quality of care.

GLOBAL INTRAVENOUS FILTER MARKET SHARE INSIGHTS

Pall Corporation stands as the frontrunner in the global IV filter market, boasting a substantial market share. The majority of its IV filters are distributed as original equipment manufacturer (OEM) devices through prominent suppliers of IV sets and IV pumps. Pall Corporation's product range encompasses filters with pore sizes of 0.2 and 1.2 micrometers, including the renowned Supor® brand, which is also employed by major competitors in the IV set market.

Securing the second position in the global IV filtration market is GVS. This company primarily operates as an OEM for filters, which are subsequently marketed and sold by other leading suppliers of IV devices. GVS offers a diverse selection of liquid IV filters, including the Speedflow brand, featuring filters with pore sizes of 0.2, 1.2, and 5.0 micrometers to cater to various filtration requirements.

ITW Filtertek specializes in producing in-line filters as integral components for other OEMs. Its product line encompasses filters designed for drug administration through infusion, total parenteral nutrition (TPN), blood transfusion, and aqueous solution infusions. The company offers a range of filters with different standard pore sizes and integration options with tubing.

MARKET SEGMENTATION SUMMARY

• Intravenous Filter Market